☆ 4.7 Letter

About Second malignancy (SM) in prostate cancer patients treated with SBRT and other contemporary radiation techniques by Edward Christopher Dee and colleagues

RADIOTHERAPY AND ONCOLOGY (2021)

Second malignancy probabilities in prostate cancer patients treated with SBRT and other contemporary radiation techniques

Edward Christopher Dee et al.

Summary: Conventionally fractionated intensity-modulated radiotherapy, moderately hypofractionated intensity-modulated radiotherapy, and brachytherapy were associated with increased probability of a second malignancy compared to radical prostatectomy, while stereotactic body radiotherapy was not. Patients treated with SBRT may have a lower risk of second malignancy due to improved conformality, radiobiological differences, or patient selection.

RADIOTHERAPY AND ONCOLOGY (2021)

添加到收藏夹

Review Oncology